Amylin as a Future Obesity Treatment
- B. Dehestani; N. R. Stratford; C. W. le Roux Amylin as a Future Obesity Treatment J Obes Metab Syndr
Publication Category: Medications
Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study
- T. Ahern; A. M. Tobin; M. Corrigan; A. Hogan; C. Sweeney; B. Kirby; D. O'Shea Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study J Eur Acad Dermatol Venereol
Can we use calorie intake and food choice measurements to determine individual variation in weight loss success to liraglutide 3.0 mg A direct method of eating behaviour assessment
-
W. Al Najim; R. T. Al Najim; N. Kapoor; G. Iatroudis; B. Dehestani; A. Grannell; J. Murphy; C. W. Le Roux
Can we use calorie intake and food choice measurements to determine individual variation in weight loss success to liraglutide 3.0 mg A direct method of eating behaviour assessment Obesity reviews
Naltrexone/bupropion for obesity
-
Naltrexone/bupropion for obesity Drug Ther Bull
A randomized controlled trial of probiotics to reduce maternal glycaemia in obese pregnancy
- K. Lindsay; O. Maguire; T. Smith; L. Brennan; F. McAuliffe A randomized controlled trial of probiotics to reduce maternal glycaemia in obese pregnancy American journal of obstetrics and gynecology
Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women
-
S. K. Ismail; L. Norris; S. O'Shea; J. R. Higgins
Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women Thromb Res
Assessing metabolic syndrome in people with ID (intellectual disabilities) on antipsychotic medication
- A. Carballedo; A. Doran; M. Doyle; S. Flavin; J. Tyrrel; F. Kelly; S. Guerin; P. Dodd Assessing metabolic syndrome in people with ID (intellectual disabilities) on antipsychotic medication Ir J Psychol Med